11 March 2025
Vaccines 2024 Young Investigator Award—Winner Announced
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
We are pleased to announce that the winner of the Vaccines 2024 Young Investigator Award is Dr. Alexandra (Ali) Dvorscek. She completed her Ph.D. in 2024 at Monash University, Australia, under the supervision of Dr. Isaak Quast and Prof. David Tarlinton. Her research focused on investigating the factors that regulate successful antibody production and immune memory formation. Dr. Dvorscek's recent work uncovered a mechanism by which the immune response to vaccination can be substantially enhanced. More specifically, by incorporating small amounts of monoclonal antibodies into vaccines, Alexandra was able to promote the magnitude, duration, and output of the immune response to both protein and mRNA vaccination. These findings can inform future vaccine design and provide insights into how the current vaccine formulations and strategies can be improved. Recently, Dr. Dvorscek relocated to the UK to pursue a postdoctoral position in the lab of Dr. Ryan Thwaites at the Imperial College, where she will investigate the immune response to influenza.
As the awardee, Dr. Alexandra Dvorscek will receive the following honorarium:
We would like to thank the award committee for their excellent work in the difficult task of selecting the winner from a pool of excellent candidates, as well as everyone who participated in this award and helped to make it such a success!
Prof. Dr. Ralph A. Tripp
Editor-in-Chief of Vaccines